BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30086794)

  • 21. Mutation and cancer: a model for human carcinogenesis.
    Moolgavkar SH; Knudson AG
    J Natl Cancer Inst; 1981 Jun; 66(6):1037-52. PubMed ID: 6941039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Psychologic Stress in Cancer Initiation: Clinical Relevance and Potential Molecular Mechanisms.
    Falcinelli M; Thaker PH; Lutgendorf SK; Conzen SD; Flaherty RL; Flint MS
    Cancer Res; 2021 Oct; 81(20):5131-5140. PubMed ID: 34266894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zebrafish Discoveries in Cancer Epigenetics.
    Chernyavskaya Y; Kent B; Sadler KC
    Adv Exp Med Biol; 2016; 916():169-97. PubMed ID: 27165354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of epigenetics in carcinogenesis.
    Lichter P
    Int J Cancer; 2008 Jul; 123(1):ix. PubMed ID: 18435465
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular epigenetics and the origin of cancer.
    Cuthill S
    Bioessays; 1994 Jun; 16(6):393-4. PubMed ID: 8080428
    [No Abstract]   [Full Text] [Related]  

  • 27. Commentary: carcinogenesis as Darwinian evolution? Do the math!
    Gatenby RA
    Int J Epidemiol; 2006 Oct; 35(5):1165-7. PubMed ID: 16990285
    [No Abstract]   [Full Text] [Related]  

  • 28. An exposure driven functional model of carcinogenesis.
    Lund E
    Med Hypotheses; 2011 Aug; 77(2):195-8. PubMed ID: 21550177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered interactions between unicellular and multicellular genes drive hallmarks of transformation in a diverse range of solid tumors.
    Trigos AS; Pearson RB; Papenfuss AT; Goode DL
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):6406-6411. PubMed ID: 28484005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recursive causality in evolution: a model for epigenetic mechanisms in cancer development.
    Haslberger A; Varga F; Karlic H
    Med Hypotheses; 2006; 67(6):1448-54. PubMed ID: 16844314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of epigenetics in cancer initiation and progression.
    Chik F; Szyf M; Rabbani SA
    Adv Exp Med Biol; 2011; 720():91-104. PubMed ID: 21901621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic dysregulation in thyroid neoplasia.
    Kondo T; Asa SL; Ezzat S
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficiency of carcinogenesis with and without a mutator mutation.
    Beckman RA; Loeb LA
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14140-5. PubMed ID: 16966602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Master and servant: epigenetic deregulations as a cause and a consequence of cancer].
    Laget S; Defossez PA
    Med Sci (Paris); 2008; 24(8-9):725-30. PubMed ID: 18789219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondria malfunctions as mediators of stem-cells' related carcinogenesis: a hypothesis that supports the highly conserved profile of carcinogenesis.
    Hatzi VI; Terzoudi GI; Pantelias GE; Makropoulos V
    Med Hypotheses; 2013 Jan; 80(1):70-4. PubMed ID: 23111201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The population dynamics of cancer: a Darwinian perspective.
    Vineis P; Berwick M
    Int J Epidemiol; 2006 Oct; 35(5):1151-9. PubMed ID: 16987840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?
    Hasselbalch HC
    Leuk Res; 2013 Feb; 37(2):214-20. PubMed ID: 23174192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced pluripotent stem cell technology for dissecting the cancer epigenome.
    Semi K; Yamada Y
    Cancer Sci; 2015 Oct; 106(10):1251-6. PubMed ID: 26224327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Models of oncogenesis: an endless world?].
    Larsen CJ
    Bull Cancer; 2013 Jun; 100(6):555-60. PubMed ID: 23719507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commentary: induction and selection of variations during cancer development.
    Jablonka E
    Int J Epidemiol; 2006 Oct; 35(5):1163-5. PubMed ID: 16990287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.